Ebenbuild focuses on personalized health intelligence for lung diseases, utilizing advanced computational models to enhance patient care. Their offerings include a digital twin platform that supports clinical decision-making and optimizes drug delivery, aiming to bridge the gap between healthcare and life sciences. The company emphasizes understanding individual patient needs to derive empirical insights for better treatment outcomes.